ZA947401B - Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles - Google Patents

Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles

Info

Publication number
ZA947401B
ZA947401B ZA947401A ZA947401A ZA947401B ZA 947401 B ZA947401 B ZA 947401B ZA 947401 A ZA947401 A ZA 947401A ZA 947401 A ZA947401 A ZA 947401A ZA 947401 B ZA947401 B ZA 947401B
Authority
ZA
South Africa
Prior art keywords
cyclodextrins
preparation
pharmaceutical compositions
active principles
absorption promoters
Prior art date
Application number
ZA947401A
Inventor
Alain Cuine
Hendrik Jan De Jong
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA947401B publication Critical patent/ZA947401B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA947401A 1993-09-22 1994-09-22 Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles ZA947401B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311258A FR2710268B1 (en) 1993-09-22 1993-09-22 Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles.

Publications (1)

Publication Number Publication Date
ZA947401B true ZA947401B (en) 1995-05-15

Family

ID=9451096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA947401A ZA947401B (en) 1993-09-22 1994-09-22 Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles

Country Status (6)

Country Link
EP (1) EP0649653A1 (en)
JP (1) JPH07247223A (en)
AU (1) AU7411194A (en)
CA (1) CA2132511A1 (en)
FR (1) FR2710268B1 (en)
ZA (1) ZA947401B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
US6740639B1 (en) * 2000-03-29 2004-05-25 Council Of Scientific & Industrial Research Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment
FR2835434B1 (en) * 2002-02-01 2006-03-03 Lvmh Rech COSMETIC OR DERMATOLOGICAL USE OF VITAMIN A OR ITS ESTERS, IN ASSOCIATION WITH A PARTIALLY METHYLATED BETA-CYCLODEXTRIN
FR2857594B1 (en) * 2003-07-17 2005-09-16 Servier Lab PHARMACEUTICAL COMPOSITION FOR NASRIAL ADMINISTRATION OF PIRIBEDIL

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
US4978532A (en) * 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
JP3207212B2 (en) * 1991-03-01 2001-09-10 久光製薬株式会社 Absorption promoter and external preparation containing the same
JPH0525046A (en) * 1991-07-18 1993-02-02 Tanabe Seiyaku Co Ltd Nicergolin preparation for transcutaneous absorption

Also Published As

Publication number Publication date
EP0649653A1 (en) 1995-04-26
FR2710268A1 (en) 1995-03-31
JPH07247223A (en) 1995-09-26
CA2132511A1 (en) 1995-03-23
FR2710268B1 (en) 1995-10-20
AU7411194A (en) 1995-04-06

Similar Documents

Publication Publication Date Title
HUP0002713A3 (en) 8-azabicyclo[3,2,1]oct-2-ene and octane derivatives, process for preparation thereof, pharmaceutical compositions comprising thereof and their use
AU627845B2 (en) Improvements in or relating to devices for administration of drugs or the like
PH30982A (en) Optically active 5H-pyrrolo Ä3,4-bÜ pyrazine derivative, its preparation and pharmaceutical compositions containing it.
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
NZ241210A (en) 16alpha,17alpha-butylidenedioxy-11b, 21-dihydroxypregn-4-ene-3,20-dione derivatives substituted in either or both the 6alpha- and 9alpha- positions by fluorine; pharmaceutical compositions, methods of preparation and treatment
AU2951489A (en) Improving the stability of pharmaceutical compositions
IL105348A0 (en) Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9700005A3 (en) 2-ureido-benzamide derivatives and pharmaceutical compositions containing them as active agent
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
AU5326598A (en) New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
IL110480A0 (en) Methylguanidine derivatives, their preparation and pharmaceutical compositions containing them
ZA947401B (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
IL164513A0 (en) Pyrazolopyrimidines, pharmaceutical compositions containing them, and their use in the preparation of medicaments
DE69414622D1 (en) Streptogramins in purified form, their preparation and pharmaceutical compositions containing them
AU8522491A (en) Substituted imidazoles, their preparation and pharmaceutical compositions
CA2322229A1 (en) Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity
AU1205792A (en) Percutaneous administration and absorption promoter composition and external preparation for percutaneous administration
IL98196A0 (en) Cephalosporin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0102086A3 (en) 8-azabicyclo[3.2.1]octane-3-methanamine derivatives and pharmaceutical compositions containing the same
IL102027A0 (en) Cephem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent